3-iodobenzylguanidine has been researched along with Hypoventilation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eriguchi, M; Fujioka, S; Hara, H; Hattori, N; Houzen, H; Li, Y; Mishima, T; Nishioka, K; Sato, K; Shiomi, K; Tsuboi, Y; Yabe, I | 1 |
| Borght, TV; Krug, B; Lacrosse, M; Luyx, D; Pirson, AS; Tuerlinckx, D | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Hypoventilation
| Article | Year |
|---|---|
Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Biomarkers; Depression; Dynactin Complex; Female; Humans; Hypoventilation; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Pedigree; Radiopharmaceuticals | 2021 |
Additional value of I-123 MIBG SPECT in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Pain; Child, Preschool; Fever of Unknown Origin; Humans; Hypoventilation; Lung Neoplasms; Male; Neuroblastoma; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |